The present invention relates to a formulation comprising the combination of dapoxetine or a pharmaceutically acceptable salt thereof and tadalafil or a pharmaceutically acceptable salt thereof. The present invention further relates to a process for preparing this formulation and to the use thereof in the treatment of the premature ejaculation related to erectile dysfunction.